Biogen/ US09062X1037 /
| 6/24/2021 9:59:56 PM | Chg. -25.62 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 349.23USD | -6.83% | 384,105 Turnover: 135.03 mill. |
-Bid Size: - | -Ask Size: - | 52.57 bill.USD | 0.00% | 14.05 |
Fundamentals
| FY 2020 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 24.86 USD | -21.00% |
| EPS Diluted: | 24.80 USD | -21.07% |
| Revenues per Share: | 83.56 USD | 8.74% |
| Book Value per Share: | 66.41 USD | -6.84% |
| Cash Flow per Share: | 26.29 USD | -30.52% |
| Dividend per Share: | 0.00 USD | - |
| Total | in mill. | |
| Revenues: | 13,444.60 USD | -6.49% |
| Net Income: | 4,000.60 USD | -32.06% |
| Operating Cash Flow: | 4,229.80 USD | - |
| Cash and Cash Equivalents: | 1,331.20 USD | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 14.05 | 9.85 |
| P/S Ratio: | 4.18 | 2.93 |
| P/BV ratio: | 5.26 | 3.69 |
| P/CF Ratio: | 13.28 | 9.31 |
| PEG: | -0.67 | -0.47 |
| Earnings Yield: | 7.12% | 10.15% |
| Dividend Yield: | 0.00% | 0.00% |
| Market Capitalization | ||
| Market Capitalization: | 52.57 bill. USD | 39.4 bill. USD |
| Free Float Market Cap.: | 38.53 bill. USD | 29.63 bill. USD |
| Market Cap. / Employee: | 6.17 mill. USD | 4.33 mill. USD |
| Shares Outstanding: | 150.55 mill. | |
Profitability
| Gross Profit Margin: | 100.00% |
| EBIT Margin: | 33.84% |
| Net Profit Margin: | 29.76% |
| Return on Equity: | 37.44% |
| Return on Assets: | 16.25% |
Financial Strength
| Liquidity I / Cash Ratio: | 69.75% |
| Liquidity II / Quick Ratio: | 120.89% |
| Liquidity III / Current Ratio: | 184.04% |
| Debt / Equity Ratio: | 130.38% |
| Dynam. Debt / Equity Ratio: | 329.40% |
Efficiency
| Employees: | 9,100 |
| Personal Expenses / Employee: | - USD |
| Revenues / Employee: | 1,477,428.57 USD |
| Net Income / Employee: | 439,626.37 USD |
| Total Assets / Employee: | 2,705,373.63 USD |
| * Fiscal Year End: | 12/31/2020 |
| Accounting Standard: | US GAAP |
| Currency: | USD |